Curetis is not your typical biotech start-up. We are rather a newcomer with many years of multi-disciplinary expertise. Over the past years we have created a healthy growth story. We have convinced our customers and partners, with our pioneering spirit, coupled with the simple aspiration „We care for Diagnostics“, our engineering prowess, and molecular biology and microbiological expertise.
We are not a typical R&D driven company. We rather put our focus on commercial product development. We listen carefully and flexibly react to market and customer demands and needs. We strive to address these by way of pragmatic and intelligent solutions such as Unyvero.
Curetis and MGI Advance Strategic Partnership in NGS-Based Molecular Microbiology
Curetis Expects Near-Term FDA Decision on De Novo Request
Reanimation Congress 2018 - Paris, France - 24 to 26 January, 2018
28. Symposium Intensivmedizin + Intensivpflege - Bremen, Germany - 14 to 16 February, 2018